Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Radiodermatitis - Overview
Radiodermatitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Radiodermatitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Radiodermatitis - Companies Involved in Therapeutics Development
Amryt Pharma Plc
BioCurity Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Foresee Pharmaceuticals Co Ltd
Jay Pharma Inc
KanLife Sciences Inc
Matrix Biomed Inc
Noveome Biotherapeutics Inc
Regeneus Ltd
RepoCeuticals ApS
Sunny Pharmtech Inc
Radiodermatitis - Drug Profiles
Biologic for Dermatology and Neuropathic Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
birch bark extract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
canbidiol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cerium oxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Enteritis, Proctitis, Pulmory Inflammation, Radiodermatitis, Xerostomia And Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FP-045 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KLS-13019 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melatonin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
phenylbutyrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RS-9 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ST-266 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tempol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZM-241385 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Radiodermatitis - Dormant Projects
Radiodermatitis - Discontinued Products
Radiodermatitis - Product Development Milestones
Featured News & Press Releases
Dec 11, 2019: Kanlife announces filing of U.S. Patent 62/934,861 - Functiolized 1, 3 Benzene Diols and their method of use for the treatment of radiation dermatitis and other skin disorders
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Radiodermatitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Radiodermatitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Radiodermatitis - Pipeline by Amryt Pharma Plc, H1 2020
Radiodermatitis - Pipeline by BioCurity Pharmaceuticals Inc, H1 2020
Radiodermatitis - Pipeline by Daiichi Sankyo Co Ltd, H1 2020
Radiodermatitis - Pipeline by Foresee Pharmaceuticals Co Ltd, H1 2020
Radiodermatitis - Pipeline by Jay Pharma Inc, H1 2020
Radiodermatitis - Pipeline by KannaLife Sciences Inc, H1 2020
Radiodermatitis - Pipeline by Matrix Biomed Inc, H1 2020
Radiodermatitis - Pipeline by Noveome Biotherapeutics Inc, H1 2020
Radiodermatitis - Pipeline by Regeneus Ltd, H1 2020
Radiodermatitis - Pipeline by RepoCeuticals ApS, H1 2020
Radiodermatitis - Pipeline by Sunny Pharmtech Inc, H1 2020
Radiodermatitis - Dormant Projects, H1 2020
Radiodermatitis - Discontinued Products, H1 2020